PDFF
Showing 1 - 25 of 220
Velacur System in Comparison to MRE & MRI-PDFF in Liver Disease
Not yet recruiting
- Non-alcoholic Fatty Liver Disease (NAFLD)
- Velacur
-
Flowood, Mississippi
- +1 more
Jun 14, 2023
Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic Steatohepatitis (NASH), Liver Fibroses Trial in Boston (Liver Incytes
Active, not recruiting
- Non-Alcoholic Fatty Liver Disease (NAFLD)
- +3 more
- Liver Incytes System
-
Boston, MassachusettsBeth Israel Deaconess Medical Centre
Dec 7, 2022
Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis Trial in Phoenix (Investigational Liver Fat Quantification
Completed
- Non-Alcoholic Fatty Liver Disease
- Non-Alcoholic Steatohepatitis
- Investigational Liver Fat Quantification Software
-
Phoenix, ArizonaPhoenix Children's Hospital
Jan 31, 2023
Diabetes Type 2, NAFLD Trial in Minya (Empagliflozin 25 MG, Ursodeoxycholic acid, Pentoxifylline 400 MG)
Completed
- Diabetes Type 2
- NAFLD
- Empagliflozin 25 MG
- +3 more
-
Minya, EgyptMinya University Hospital
Jul 20, 2022
Assessment of Fatty Liver With Thermo-acoustic Device
Not yet recruiting
- NASH
- +6 more
- Thermo-acuostic image acquisition of liver
- MRI-PDFF estimation of hepatic fat
-
Milwaukee, WisconsinFroedtert Hospital
May 23, 2022
Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis Trial in Boston, Boardman (Investigational Liver Fat
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Non-Alcoholic Steatohepatitis
- Investigational Liver Fat Quantification Software
-
Boston, Massachusetts
- +2 more
May 23, 2022
Pharmacokinetics of Miricorilant in Presumed Nonalcoholic
Recruiting
- Nonalcoholic Steatohepatitis (NASH)
- MRI-PDFF
-
Chandler, Arizona
- +7 more
Apr 8, 2022
Hepatocellular Carcinoma, Nonalcoholic Steatohepatitis Trial in Tarzana, New York, Durham (Lisinopril, Questionnaire
Recruiting
- Hepatocellular Carcinoma
- Nonalcoholic Steatohepatitis
- Biospecimen Collection
- +6 more
-
Los Angeles, California
- +3 more
Dec 8, 2022
Hypercholesterolemia Trial (HSK31679 low dose, HSK31679 medium dose, HSK31679 high dose)
Not yet recruiting
- Hypercholesterolemia
- HSK31679 low dose
- +4 more
- (no location specified)
Mar 20, 2023
Non-alcoholic Fatty Liver Disease Trial in China, Switzerland (Hepatic fat fraction and hepatic fibrosis)
Recruiting
- Non-alcoholic Fatty Liver Disease
- Hepatic fat fraction and hepatic fibrosis
-
Bozhou, Anhui, China
- +13 more
Apr 6, 2023
Non-alcoholic Fatty Liver Disease Trial in Hong Kong (Empagliflozin 10 MG, Placebo pills)
Active, not recruiting
- Non-alcoholic Fatty Liver Disease
- Empagliflozin 10 MG
- Placebo pills
-
Hong Kong, Hong Kong, China, Hong KongThe University of Hong Kong/Queen Mary Hospital
May 24, 2022
Fatty Liver, Fatty Liver, Nonalcoholic Trial in Seoul (Quantitative US (Samsung Medison, RS85A))
Completed
- Fatty Liver
- Fatty Liver, Nonalcoholic
- Quantitative US (Samsung Medison, RS85A)
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 3, 2022
Liver Disease in Patients Dependent on Parenteral Nutrition
Recruiting
- Intestinal Failure-associated Liver Disease
-
Los Angeles, California
- +8 more
Jul 7, 2022
Diabetes, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease Trial (MN-001, MN-001 )
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- MN-001
- MN-001 placebo
- (no location specified)
Jul 15, 2022
Non-Alcoholic Fatty Liver Disease, Fecal Microbiota Transplantation Trial in London (Faecal microbiota transplant)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Fecal Microbiota Transplantation
- Faecal microbiota transplant
-
London, United KingdomDivision of Digestive Diseases/ Liver Unit, St Mary's Hospital C
Aug 29, 2023
Accurate Point of Care Liver Disease Diagnostics
Recruiting
- NAFLD
- Nonalcoholic Fatty Liver
- Liverscope® exam
- +5 more
-
La Jolla, CaliforniaUniversity of California San Diego
Aug 8, 2023
Non-Alcoholic Fatty Liver Disease Trial in Shanghai (2D ultrasound scan and MRI examination)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- 2D ultrasound scan and MRI examination
-
Shanghai, ChinaXinhua Hospital affiliated to Shanghai Jiao Tong University Scho
Oct 18, 2023
cT1 for NASH (CATE-NASH)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- LiverMultiscan
-
Boston, MassachusettsMassachusetts General Hospital
Nov 30, 2021
Liver Transplant; Complications, Diabete Mellitus Trial (Semaglutide Pill)
Not yet recruiting
- Liver Transplant; Complications
- Diabete Mellitus
- Semaglutide Pill
- (no location specified)
Sep 23, 2023
Non-Alcoholic Fatty Liver Disease, Non Alcoholic Fatty Liver, Hepatic Steatosis Trial in Kyiv, Lviv (Probiotic lysate
Recruiting
- Non-Alcoholic Fatty Liver Disease
- +3 more
- Probiotic lysate (postbiotic and metabiotc)
- Placebo
-
Kyiv, Ukraine
- +3 more
Mar 27, 2023
NASH, NAFLD Trial in Hangzhou (GH509, Placebo)
Recruiting
- NASH
- NAFLD
- GH509
- Placebo
-
Hangzhou, Zhejiang, ChinaThe Affiliated Hospital of Hangzhou Normal University
Mar 26, 2023
Type 2 Diabetes, Non Alcholic Fatty Liver Disease Trial (Bempedoic acid)
Not yet recruiting
- Type 2 Diabetes
- Non Alcholic Fatty Liver Disease
- Bempedoic acid
- (no location specified)
Sep 14, 2023
Using Ultrasound and Artificial Intelligence
Active, not recruiting
- Steatotic Liver Disease
- +2 more
-
Bari, BA, ItalyDepartment of Department of Precision and Regenerative Medicine
Oct 21, 2023
Electrical Impedance Tomography in Fatty Liver Detection
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Electrical impedance tomography
-
Hong Kong, Select A State Or Province, ChinaThe University of Hong Kong
Jan 8, 2022
Nonalcoholic Steatohepatitis (NASH), Metabolic Dysfunction-associated Steatohepatitis (MASH) Trial in Hialeah Gardens
Recruiting
- Nonalcoholic Steatohepatitis (NASH)
- Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Miricorilant
- Placebo
-
Hialeah Gardens, FloridaSite #430
Nov 1, 2023